POL: Efficacy of CHX Cloths Versus CHX Soaps for Bathes Before Orthopedic Surgery

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05120739
Collaborator
(none)
64
1
2
11
5.8

Study Details

Study Description

Brief Summary

Surgical site infections (SSI) in orthopedic surgery are rare events but associated with great morbidity as well as a significant additional cost. The World Health Organization (WHO) recently carried out meta-analyzes on all the existing prophylactic measures and could not rule on the use of chlorhexidine (CHX) cloths due to the low number of studies available. CHX cloths could actually benefit patients for whom preoperative showering is not possible, whether in emergency or trauma settings due to pain-induced functional impotence. A randomized controlled clinical study aimed at evaluating the in vivo microbiological efficacy of CHX cloths in a population of orthopedic surgery patients while evaluating the psycho-social determinants of adherence to a new preoperative preparation technique seems essential.

Condition or Disease Intervention/Treatment Phase
  • Drug: 2% CHX cloths
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
64 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Skin Preparation of Patients Before Orthopedic Surgery : A Randomized Controlled Study on the Efficacy of Chlorhexidine Cloths Versus Chlorhexidine Soaps
Anticipated Study Start Date :
Nov 15, 2021
Anticipated Primary Completion Date :
May 15, 2022
Anticipated Study Completion Date :
Oct 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional

Skin preparations (the day before and the morning of the operation) with the 2% CHX cloths

Drug: 2% CHX cloths
skin preparation in 2% CHX cloths

No Intervention: Control

Skin preparations (the day before and the morning of the operation) with the 4% CHX soap (standard of care)

Outcome Measures

Primary Outcome Measures

  1. Relative decrease in the number of bacterial colonies before the antiseptic preparation of the operating site at the surgical room (T1) [Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)]

    Relative decrease in the number of bacterial colonies measured between the patient's admission to the Grenoble Alps University Hospital (CHU GA) (T0) and after 2 preoperative skin preparations (the day before and the morning of the operation), and just before the antiseptic preparation of the operating site at the surgical room (T1) in the 2% CHX cloths group versus the 4% CHX soap group.

Secondary Outcome Measures

  1. Relative decrease in the number of bacterial colonies after 1 preoperative skin preparation [Between the patient's admission to the CHU GA and after 1 preoperative skin preparation (Day 0)]

    Relative decrease in the number of bacterial colonies measured between the patient's admission to the CHU GA (T0) and after 1 preoperative skin preparation (the day before the evening of the operation)

  2. Relative decrease in the number of bacterial colonies after 2 preoperative skin preparations [Between the patient's admission to the CHU GA and after 2 preoperative skin preparations (Day 1)]

    Relative decrease in the number of bacterial colonies measured between the patient's admission to the CHU GA (T0) and after 2 preoperative skin preparations (the night before and the morning of the operation)

  3. Significant predictors of a decrease in bacterial colonization [Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)]

    Significant predictors of a decrease in bacterial colonization among the sex, age of the patients, their co-morbidities, the use of cloths and the time between the last preoperative skin preparation and the skin sample in the operating room

  4. Percentage of skin adverse reactions [Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)]

    Percentage of skin adverse reactions after 2 preoperative skin preparations in the 2% CHX cloths group versus the 4% CHX soap group.

  5. Nursing load [Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)]

    Nursing load in the 2% CHX cloths group versus 4% CHX soap group according to the Soins Infirmiers Individualisés à la Personne Soignée (SIIPS) scale

  6. Duration of preoperative skin preparation [Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)]

    Duration of preoperative skin preparation in minutes in the 2% CHX cloths group versus 4% CHX soap group.

  7. Responses to a questionnaire for patients and adherence score [Between surgery and discharge from the hospital (Day 4)]

    Responses to a questionnaire for patients and adherence score in the 2% CHX cloths group versus the 4% CHX soap group.

  8. Responses to a semi-structured interview intended for healthcare professionals [Interview at the end of the inclusion of patients (through study completion, an average of 6 months)]

    Responses to a semi-structured interview intended for healthcare professionals who cared for patients randomized to the 2% CHX cloths group versus the 4% CHX soap group.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult patients,

  • undergoing orthopedic surgery: programmed hip prosthesis (non-urgent),

  • admitted the day before the operation

  • and having given their written consent.

Exclusion Criteria:
  • presence of a documented infection at the time of the intervention,

  • presence of skin wounds,

  • presence of antibiotic treatment within 15 days before the operation

  • intolerance to CHX,

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu de Grenoble Alpes Grenoble France 38700

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT05120739
Other Study ID Numbers:
  • 38RC19.254
First Posted:
Nov 15, 2021
Last Update Posted:
Nov 15, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Grenoble

Study Results

No Results Posted as of Nov 15, 2021